ConductScience.org, home

Paper39576992

Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19.

Zhu W and 24 others. Blood, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19. Papers, record 39576992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39576992

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19.
PubMed
Journal
Blood
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.73, provisional
iCite
Revised in PubMed
2026-10-28
PubMed

Authors25

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
Spike Glycoprotein, CoronavirusMajor topic
SARS-CoV-2Major topic
Antibodies, ViralMajor topic
AutoantibodiesMajor topic
Humans
Immunoglobulin G
Male
Female
Platelet Activation
Middle Aged
Platelet Factor 4
Aged
Protein Domains
Heparin
Blood Platelets
Thrombocytopenia
Adult
P-Selectin

Source PubMed

Download CSV of topics

Grants12

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 HL167668NHLBI NIH HHSUnited StatesP01HL167668PubMed and NIHNIH RePORTER
R01 HL161127NHLBI NIH HHSUnited StatesR01HL161127PubMed and NIHNIH RePORTER
R01 HL148120NHLBI NIH HHSUnited StatesR01HL148120PubMed and NIHNIH RePORTER
R56 AI159536NIAID NIH HHSUnited StatesR56AI159536PubMed and NIHNIH RePORTER
R01 HL158932NHLBI NIH HHSUnited StatesR01HL158932PubMed and NIHNIH RePORTER
P01 HL044612NHLBI NIH HHSUnited StatesP01HL044612PubMed and NIHNIH RePORTER
UL1 TR001436NCATS NIH HHSUnited StatesUL1TR001436PubMed and NIHNIH RePORTER
T32 GM080202NIGMS NIH HHSUnited StatesT32GM080202PubMed and NIHNIH RePORTER
R01 AI079087NIAID NIH HHSUnited StatesR01AI079087PubMed and NIHNIH RePORTER
R01 HL130724NHLBI NIH HHSUnited StatesR01HL130724PubMed and NIHNIH RePORTER
OT2 HL156812NHLBI NIH HHSUnited StatesOT2HL156812PubMed and NIHNIH RePORTER
R01 HL175474NHLBI NIH HHSUnited StatesR01HL175474PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in39913341Antibodies to PF4 in severe COVID-19: same but different.https://conductscience.org/library/papers/39913341

Source PubMed

Download CSV of comments and corrections

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115738055Defective B cell tolerance checkpoints in systemic lupus erythematosus.J Exp Med2005https://conductscience.org/library/papers/15738055PubMed
233397677Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals.Sci Transl Med2021https://conductscience.org/library/papers/33397677PubMed
314699083Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies.J Exp Med2004https://conductscience.org/library/papers/14699083PubMed
434413139Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.Sci Immunol2021https://conductscience.org/library/papers/34413139PubMed
532091533Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.JAMA2020https://conductscience.org/library/papers/32091533PubMed
633123171Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD).Front Immunol2020https://conductscience.org/library/papers/33123171PubMed
732555388Convergent antibody responses to SARS-CoV-2 in convalescent individuals.Nature2020https://conductscience.org/library/papers/32555388PubMed
827096317Recognition of Endogenous Nucleic Acids by the Innate Immune System.Immunity2016https://conductscience.org/library/papers/27096317PubMed
934010947Diverse functional autoantibodies in patients with COVID-19.Nature2021https://conductscience.org/library/papers/34010947PubMed
1033630053Another front in COVID-19's perfect storm.Blood2021https://conductscience.org/library/papers/33630053PubMed
1129314720Correlation of APRIL with production of inflammatory cytokines during acute malaria in the Brazilian Amazon.Immun Inflamm Dis2018https://conductscience.org/library/papers/29314720PubMed
1226905366A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.Chest2016https://conductscience.org/library/papers/26905366PubMed
1323071157Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis.Circ Res2013https://conductscience.org/library/papers/23071157PubMed
1432369280Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.N Engl J Med2020https://conductscience.org/library/papers/32369280PubMed
1525775976The platelet serotonin-release assay.Am J Hematol2015https://conductscience.org/library/papers/25775976PubMed
1635560046Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT.Blood2022https://conductscience.org/library/papers/35560046PubMed
1724677540Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder.Blood2014https://conductscience.org/library/papers/24677540PubMed
1832849618Maturation of the Human Immunoglobulin Heavy Chain Repertoire With Age.Front Immunol2020https://conductscience.org/library/papers/32849618PubMed
1932597954Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome.Blood2020https://conductscience.org/library/papers/32597954PubMed
2035225150Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology.Platelets2022https://conductscience.org/library/papers/35225150PubMed

See all 91 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42539105Charge-driven antiviral responses enhance autoreactivity in severe COVID-19.Res Sq2026https://conductscience.org/library/papers/42539105PubMed
42361778Comparison of Igκ and Igλ binding toward influenza virus hemagglutinin and SARS-CoV-2 Spike protein during primary viral infections in humans, mice, and pigs.Comp Immunol Microbiol Infect Dis2026https://conductscience.org/library/papers/42361778PubMed
42013023Non-PF4/heparin-binding, platelet-activating antibodies in heparin-induced thrombocytopenia.Blood2026https://conductscience.org/library/papers/42013023PubMed
41746733Atypical memory B cell clonal expansion and inflammatory programs associate with platelet-activating antibody development in COVID-19.JCI Insight2026https://conductscience.org/library/papers/41746733PubMed
41112288Post-COVID syndrome patients show reduced anti-Spike antibodies compared to COVID-recovered controls, but enhanced IgG4/IgG1 switch after the third vaccine dose.Front Immunol2025https://conductscience.org/library/papers/41112288PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PF45196PubTator's text mininghttps://conductscience.org/library/genes/5196NCBI Gene
SELP6403PubTator's text mininghttps://conductscience.org/library/genes/6403NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39576992

GET https://conductscience.org/api/papers/v1/39576992/authors?page=2